Cargando…
First person – Sara Ibrahim
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sara Ibrahim is first author on ‘A novel Cre-enabled tetracycline-inducible transgenic syst...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328170/ http://dx.doi.org/10.1242/dmm.045195 |
_version_ | 1783552690599493632 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sara Ibrahim is first author on ‘A novel Cre-enabled tetracycline-inducible transgenic system for tissue-specific cytokine expression in the zebrafish: CETI-PIC3’, published in DMM. Sara is an MD-PhD student in the lab of Emily K. Sims and Ryan M. Anderson at Indiana University School of Medicine, Indianapolis, IN, USA, developing and utilizing molecular biology techniques to study β cell dysfunction. |
format | Online Article Text |
id | pubmed-7328170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-73281702020-07-01 First person – Sara Ibrahim Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sara Ibrahim is first author on ‘A novel Cre-enabled tetracycline-inducible transgenic system for tissue-specific cytokine expression in the zebrafish: CETI-PIC3’, published in DMM. Sara is an MD-PhD student in the lab of Emily K. Sims and Ryan M. Anderson at Indiana University School of Medicine, Indianapolis, IN, USA, developing and utilizing molecular biology techniques to study β cell dysfunction. The Company of Biologists Ltd 2020-06-26 /pmc/articles/PMC7328170/ http://dx.doi.org/10.1242/dmm.045195 Text en © 2020. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Sara Ibrahim |
title | First person – Sara Ibrahim |
title_full | First person – Sara Ibrahim |
title_fullStr | First person – Sara Ibrahim |
title_full_unstemmed | First person – Sara Ibrahim |
title_short | First person – Sara Ibrahim |
title_sort | first person – sara ibrahim |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328170/ http://dx.doi.org/10.1242/dmm.045195 |